Full View

ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane‐based chemotherapy

J Zhong, Z Guo, L Fan, X Zhao, B Zhao, Z Cao… - Thoracic …, 2019 - Wiley Online Library
Background Taxane‐based chemotherapy is widely used in lung cancer. ABCB1 have a
role in the prediction of treatment response and toxicity of chemotherapy in solid tumors. In …
被引用次数：23 相关文章

ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane‐based chemotherapy

J Zhong, Z Guo, L Fan, X Zhao, B Zhao, Z Cao… - Thoracic …, 2019 - search.proquest.com
Background Taxane‐based chemotherapy is widely used in lung cancer. ABCB1 have a
role in the prediction of treatment response and toxicity of chemotherapy in solid tumors. In …

ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane-based chemotherapy.

J Zhong, Z Guo, L Fan, X Zhao, B Zhao, Z Cao… - Thoracic …, 2019 - europepmc.org
BACKGROUND: Taxane-based chemotherapy is widely used in lung cancer. ABCB1 have a
role in the prediction of treatment response and toxicity of chemotherapy in solid tumors. In …

ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane-based chemotherapy

J Zhong, Z Guo, L Fan, X Zhao, B Zhao… - Thoracic …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Taxane-based chemotherapy is widely used in lung cancer. ABCB1 have a role
in the prediction of treatment response and toxicity of chemotherapy in solid tumors. In this …
[HTML] nih.gov

[HTML][HTML] ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane‐based chemotherapy

J Zhong, Z Guo, L Fan, X Zhao, B Zhao, Z Cao… - Thoracic …, 2019 - ncbi.nlm.nih.gov
Background Taxane‐based chemotherapy is widely used in lung cancer. ABCB1 have a
role in the prediction of treatment response and toxicity of chemotherapy in solid tumors. In …